Refine by
Diarrhea Technology
8 companies found
Technologybased inMountain View, CALIFORNIA (USA)
Osel’s mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. In 2003, Osel was one of the first companies to ...
CBM588 is an orally-administered Clostridium butyricum strain with a long history of clinical use and safety in all age groups in Japan. In Japan, CBM588 has primarily been used to treat infectious and noninfectious diarrheal disorders associated ...
Technologybased inRahway, NEW JERSEY (USA)
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of ...
DIFICID is a macrolidc antibacterial indicated in adult and pediatric patients 6 months of age and older for the treatment of C. difficile-as&ocizicA diarrhea. (1.1). To reduce the development of drug-resistant bacteria and ...
Technologybased inParis, FRANCE
CHROMagar™ was incorporated in 1993 by the inventor, and pioneer in chromogenic culture media technology, Dr Alain Rambach. Established in the heart of Paris (France) close to the famous Pasteur Institute where Dr Rambach began his research career, ...
CHROMagar™ C.difficile is a selective and differential fluorogenic culture medium, intended for use in the qualitative direct detection of gastrointestinal colonization with Clostridioides difficile to aid in the prevention and control in ...
Technologybased inChino, CALIFORNIA (USA)
Our mission at Specialty Enzymes & Probiotics is to improve the well-being of families across the globe, helping you bring people and their pets natural, efficacious ingredients to promote systemic, gut and immune health. We are enzyme pioneers in ...
Proven and effective digestive enzyme blends to promote optimal digestion and nutrient absorption. Supports digestion of foods ranging from legumes, milk, soy, cereal grains to meat. Supports breakdown of carbohydrates, fats, proteins and dairy ...
Technologybased inWildau, GERMANY
Behind BIOMES is a team of passionate and experienced scientists. We built our company on the basis of years of research work with the goal of making cutting-edge technologies accessible to everyone. Our vision: We want to help people live healthier ...
PREMIUM.pro contains 15 highly active bacterial cultures (11.2 billion microorganisms) that occur naturally in the human intestine (e.g. Lactobacillus, Bifidobacterium and Bacillus coagulans), as well as vitamins, active yeast and magnesium. ...
Technologybased inBengaluru, INDIA
At OncoStem, we develop innovative prognostic tests that assess aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. Since 2011, our vision is to empower the ...
CanAssist Breast is a prognostic test developed by OncoStem that classifies the patients as ‘low-risk’ or ‘high-risk’ based on the patient’s risk of breast cancer recurrence over five years. CanAssist Breast ...
Technologybased inSaint-Herblain, FRANCE
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has several vaccines in development, including unique vaccines ...
IXIARO® is a vaccine indicated for the prevention of disease caused by JE virus, approved for use in individuals 2 months of age and older. Severe allergic reaction after a previous dose of IXIARO®, any other JEV vaccine, or any component of ...
Technologybased inWoburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Despite the widespread use of the 5-HT3 receptor antagonist anti-emetics such as Palonosetron (Aloxi; Eisai), Ondansetron (Zofran®; GSK), Granisetron (Kytril®; Roche Pharmaceuticals), and Dolasetron (Anzemet®; Aventis), CINV continues to ...